ATE189772T1 - Unter wärmeeinwirkung reversibel gelierende medizinische zusammensetzung auf wasserbasis - Google Patents

Unter wärmeeinwirkung reversibel gelierende medizinische zusammensetzung auf wasserbasis

Info

Publication number: ATE189772T1
Authority: AT; Austria
Prior art keywords: water; under heat; medical composition; based medical; gels
Prior art date: 1993-04-16

Application number

AT93924801T

Other languages

English (en)

Inventor

Masanobu Takeuchi

Hiroe Suzuki

Toshie Takahashi

Hiroki Maruyama

Miyako Sasaki

Keiko Naitou

Touru Oguma

Masayoshi Goto

Original Assignee

Wakamoto Pharma Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-04-16

Filing date

1993-11-10

Publication date

2000-03-15

1993-11-10 Application filed by Wakamoto Pharma Co Ltd filed Critical Wakamoto Pharma Co Ltd

2000-03-15 Application granted granted Critical

2000-03-15 Publication of ATE189772T1 publication Critical patent/ATE189772T1/de

Links

239000000203 mixture Substances 0.000 title abstract 3
239000000499 gel Substances 0.000 title abstract 2
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 abstract 3
LNAZSHAWQACDHT-XIYTZBAFSA-N (2r,3r,4s,5r,6s)-4,5-dimethoxy-2-(methoxymethyl)-3-[(2s,3r,4s,5r,6r)-3,4,5-trimethoxy-6-(methoxymethyl)oxan-2-yl]oxy-6-[(2r,3r,4s,5r,6r)-4,5,6-trimethoxy-2-(methoxymethyl)oxan-3-yl]oxyoxane Chemical compound CO[C@@H]1[C@@H](OC)[C@H](OC)[C@@H](COC)O[C@H]1O[C@H]1[C@H](OC)[C@@H](OC)[C@H](O[C@H]2[C@@H]([C@@H](OC)[C@H](OC)O[C@@H]2COC)OC)O[C@@H]1COC LNAZSHAWQACDHT-XIYTZBAFSA-N 0.000 abstract 1
239000002202 Polyethylene glycol Substances 0.000 abstract 1
230000036760 body temperature Effects 0.000 abstract 1
238000003745 diagnosis Methods 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
230000000694 effects Effects 0.000 abstract 1
230000009969 flowable effect Effects 0.000 abstract 1
229920000609 methyl cellulose Polymers 0.000 abstract 1
239000001923 methylcellulose Substances 0.000 abstract 1
229960002900 methylcellulose Drugs 0.000 abstract 1
235000010981 methylcellulose Nutrition 0.000 abstract 1
238000011422 pharmacological therapy Methods 0.000 abstract 1
229920001223 polyethylene glycol Polymers 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A61K47/38—Cellulose; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Life Sciences & Earth Sciences (AREA)
Inorganic Chemistry (AREA)
Engineering & Computer Science (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Oil, Petroleum & Natural Gas (AREA)
Dermatology (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Materials For Medical Uses (AREA)
Compositions Of Macromolecular Compounds (AREA)

AT93924801T 1993-04-16 1993-11-10 Unter wärmeeinwirkung reversibel gelierende medizinische zusammensetzung auf wasserbasis ATE189772T1 (de)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
JP11234593		1993-04-16
PCT/JP1993/001636 WO1994023750A1 (fr)	1993-04-16	1993-11-10	Composition medicamenteuse se tranformant en gel thermiquement de façon reversible

Publications (1)

Publication Number	Publication Date
ATE189772T1 true ATE189772T1 (de)	2000-03-15

Family

ID=14584369

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT93924801T ATE189772T1 (de)	1993-04-16	1993-11-10	Unter wärmeeinwirkung reversibel gelierende medizinische zusammensetzung auf wasserbasis

Country Status (16)

Country	Link
US (1)	US5624962A (de)
EP (1)	EP0694310B1 (de)
KR (1)	KR0162025B1 (de)
CN (1)	CN1048393C (de)
AT (1)	ATE189772T1 (de)
AU (1)	AU668447B2 (de)
CA (1)	CA2153234C (de)
DE (1)	DE69327878T2 (de)
DK (1)	DK0694310T3 (de)
ES (1)	ES2141775T3 (de)
FI (1)	FI112778B (de)
HU (1)	HU220864B1 (de)
IL (1)	IL107626A (de)
NO (1)	NO311635B1 (de)
RU (1)	RU2108112C1 (de)
WO (1)	WO1994023750A1 (de)

Families Citing this family (87)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6436425B1 (en)	1988-11-16	2002-08-20	Mdv Technologies, Inc.	Method and non-gelling composition for inhibiting post-surgical adhesions
US5346703A (en)	1990-08-07	1994-09-13	Mediventures, Inc.	Body cavity drug delivery with thermo-irreversible polyoxyalkylene and ionic polysaccharide gels
US5318780A (en) *	1991-10-30	1994-06-07	Mediventures Inc.	Medical uses of in situ formed gels
JP3981151B2 (ja) *	1994-03-28	2007-09-26	ザトラスティーズオブコロンビアユニバーシティーインザシティーオブニューヨーク	液体中の刺激物を不活化するための組成物
US5756552A (en) *	1994-10-13	1998-05-26	Wakamoto Pharmaceutical Co., Ltd.	Lyophilized pharmaceutical preparations capable of providing aqueous drug composition having property of reversible thermosetting gelation
DE19511322C2 (de)	1995-03-28	1999-09-02	Mann Gerhard Chem Pharm Fab	Sterile Augengele mit einem Gehalt an mittelkettigen Triglyceriden und Verfahren zu deren Herstellung
US5843470A (en)	1995-10-06	1998-12-01	Mdv Technologies, Inc.	Method and composition for inhibiting post-surgical adhesions
CA2232855C (en) *	1997-04-10	2007-10-09	Roche Consumer Health (Worldwide) Sa	Pharmaceutical formulation
WO1998051281A1 (en) *	1997-05-14	1998-11-19	Senju Pharmaceutical Co., Ltd.	Aqueous suspension preparations with excellent redispersibility
EP1039932A1 (de) *	1997-12-23	2000-10-04	Alliance Pharmaceutical Corporation	Verfahren und zusammensetzungenzur verabreichung pharmazeutischer wirkstoffeund/oder der prävention von adhesion
US6197347B1 (en)	1998-06-29	2001-03-06	Andrx Pharmaceuticals, Inc.	Oral dosage for the controlled release of analgesic
ES2155027B1 (es) *	1999-05-24	2001-12-01	Univ Pais Vasco	Geles para propositos multiples, reversibles y degradables.
AU769853B2 (en) *	1999-06-11	2004-02-05	Atossa Genetics, Inc.	Gel composition for filing a breast milk duct prior to surgical excision of the duct or other breast tissue
US20020061281A1 (en) *	1999-07-06	2002-05-23	Osbakken Robert S.	Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6576224B1 (en) *	1999-07-06	2003-06-10	Sinuspharma, Inc.	Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
US6777429B1 (en) *	1999-07-23	2004-08-17	Novartis Ag	Ophthalmic composition
JP2001158750A (ja) *	1999-12-02	2001-06-12	Lion Corp	眼科用組成物及び抗アレルギー薬の持続性向上方法
RU2156128C1 (ru) *	2000-01-05	2000-09-20	Гапонюк Петр Яковлевич	Глазные капли для лечения воспалительных заболеваний глаз с аллергическими проявлениями
JP3450805B2 (ja) *	2000-08-08	2003-09-29	わかもと製薬株式会社	水性医薬組成物
US7420030B2 (en)	2000-09-08	2008-09-02	The Board Of Regents Of The University Of Texas System	Aminopeptidase A (APA) targeting peptides for the treatment of cancer
EP1328214A4 (de) *	2000-09-20	2009-07-29	Shahinian Lee Jr	Selbstkonservierende nasale, inhalierbare und topische ophthalmische präparate und medikamente
JP4820024B2 (ja) *	2001-01-10	2011-11-24	昭和薬品化工株式会社	局所麻酔用組成物
EP1418932A4 (de) *	2001-07-18	2006-03-15	Univ Texas	Antiangiogener zustand bei mäusen und menschen mit retinaler photorezeptor-degeneration
US20040048243A1 (en) *	2001-09-07	2004-03-11	Wadih Arap	Methods and compositions for in vitro targeting
US6846846B2 (en)	2001-10-23	2005-01-25	The Trustees Of Columbia University In The City Of New York	Gentle-acting skin disinfectants
RU2191581C1 (ru) *	2001-11-16	2002-10-27	Нестерук Владимир Викторович	Способ получения раствора фторурацила
US7745425B2 (en) *	2002-02-07	2010-06-29	The Trustees Of Columbia University In The City Of New York	Non-irritating compositions containing zinc salts
US7879365B2 (en)	2002-02-07	2011-02-01	The Trustees Of Columbia University In The City Of New York	Zinc salt compositions for the prevention of dermal and mucosal irritation
WO2003066001A2 (en)	2002-02-07	2003-08-14	The Trustees Of Columbia University In The City Of New York	Zinc salt compositions for the prevention of mucosal irritation from spermicides and microbicides
PT1484054E (pt) *	2002-02-22	2012-11-28	Santen Pharmaceutical Co Ltd	Sistema de administração de fármaco para administração subconjuntival de partículas finas
TW200304812A (en) *	2002-03-08	2003-10-16	Sankyo Co	An eye drop containing a tetrazole derivative
US20030211173A1 (en) *	2002-05-08	2003-11-13	Veach Tom C.	Lubrication composition
RU2228741C2 (ru) *	2002-05-23	2004-05-20	Сотникова Лариса Федоровна	Способ лечения рецидивирующего иридоциклохориоидита лошадей
RU2228742C2 (ru) *	2002-05-23	2004-05-20	Сотникова Лариса Федоровна	Способ лечения рецидивирующего иридоциклохориоидита лошадей
WO2004026953A1 (ja) *	2002-09-18	2004-04-01	Wakamoto Pharmaceutical Co.,Ltd.	透明な可逆性熱ゲル化水性組成物
RU2238092C2 (ru) *	2002-10-08	2004-10-20	Нестерук Владимир Викторович	Водная лекарственная композиция для лечения заболеваний кожи
US7220431B2 (en)	2002-11-27	2007-05-22	Regents Of The University Of Minnesota	Methods and compositions for applying pharmacologic agents to the ear
JP2004196787A (ja) *	2002-12-04	2004-07-15	Santen Pharmaceut Co Ltd	結膜下デポによるドラッグデリバリーシステム
US20060216245A1 (en) *	2002-12-10	2006-09-28	Showa Yakuhin Kako Co., Ltd.	Composition for local anesthesia
US20050085446A1 (en) *	2003-04-14	2005-04-21	Babu M.K. M.	Fluoroquinolone formulations and methods of making and using the same
JP4669960B2 (ja) *	2003-06-03	2011-04-13	株式会社メドレックス	局所麻酔薬を含有する口中用または咽頭部用製剤
BRPI0412675A (pt) *	2003-07-17	2006-10-03	Univ Columbia	composições antimicrobianas contendo combinações sinergìsticas de compostos de amÈnio quaternário e óleos essenciais e/ou constituintes
WO2005018608A1 (ja) *	2003-08-20	2005-03-03	Santen Pharmaceutical Co., Ltd.	微粒子テノン嚢下投与ドラッグデリバリーシステム
RU2245134C1 (ru) *	2003-09-02	2005-01-27	Открытое акционерное общество "Красфарма"	Состав офлоксацина для инъекций
FR2860718B1 (fr) *	2003-10-09	2006-02-24	Jean Pascal Conduzorgues	Nouvelle formulation et ses applications dans le domaines cosmetiques ou pharmaceutiques
EP1708668A1 (de) *	2004-01-15	2006-10-11	Oral Bioscience Pty. Limited	Anästhesierendes gel zur anwendung im mund
US7658947B2 (en)	2004-06-25	2010-02-09	Kimberly-Clark Worldwide, Inc.	Thermo-gelling composition
JP2007277095A (ja) *	2004-07-02	2007-10-25	Wakamoto Pharmaceut Co Ltd	アジスロマイシン含有可逆性熱ゲル化水性組成物
US7459416B2 (en) *	2004-07-12	2008-12-02	Panasonic Corporation	Fluid bearing unit and spindle motor using the same
RU2281086C1 (ru) *	2005-01-18	2006-08-10	Сергей Николаевич Анисимов	Глазные антигистаминные капли
BRPI0608690B8 (pt)	2005-03-10	2021-05-25	3M Innovative Properties Co	uso de uma composição antimicrobiana
JP4979258B2 (ja) *	2005-04-08	2012-07-18	ロート製薬株式会社	アシタザノラスト含有水性組成物
CN100463668C (zh) *	2005-05-09	2009-02-25	凌沛学	可逆性热凝胶化水性药物组合物
CN100430069C (zh) *	2005-07-28	2008-11-05	凌沛学	一种中药及其复方的可逆性热凝胶化水性药物组合物
PT1938820E (pt) *	2005-10-17	2010-04-01	Kowa Co	Preparação líquida para aplicação externa contendo indometacina
EA008737B1 (ru) *	2005-12-07	2007-08-31	Леонид Андреевич Кожемякин	Средство для профилактики и лечения конъюнктивитов и кератитов различной этиологии (варианты), способ его применения
US7759327B2 (en) *	2006-01-06	2010-07-20	The Trustees Of Columbia University In The City Of New York	Compositions containing zinc salts for coating medical articles
US20070249546A1 (en) *	2006-04-22	2007-10-25	Sawaya Assad S	Ophthalmic and related aqueous solutions containing antifungal agents, uses therefor and methods for preparing them
US20070253909A1 (en) *	2006-05-01	2007-11-01	Medi-Flex, Inc.	Aqueous Antiseptic Solution and Compatible Cationic Dye for Staining Skin
US20070254854A1 (en) *	2006-05-01	2007-11-01	Medi-Flex, Inc.	Aqueous Antiseptic Solution and Compatible Anionic Dye for Staining Skin
US20080108674A1 (en) *	2006-05-01	2008-05-08	Enturia, Inc.	Cationic antiseptic and dye formulation
TW200808375A (en) *	2006-05-12	2008-02-16	Otsuka Pharma Co Ltd	Hydrogel suspension and manufacturing process thereof
EA014780B1 (ru) *	2007-01-05	2011-02-28	Промед Экспортс Пвт. Лтд.	Офтальмическая композиция
DE102007002073A1 (de) *	2007-01-09	2008-07-10	Matthias Habenicht	Mittel zur Pflege und antimikrobiellen Behandlung der Haut
EP2172224A4 (de) *	2007-06-26	2013-01-16	Wakamoto Pharma Co Ltd	Wässrige zusammensetzung
PT2193795E (pt) *	2007-08-29	2014-10-22	Wakamoto Pharma Co Ltd	Composição farmacêutica aquosa contendo latanoprost
WO2009074853A2 (en) *	2007-12-10	2009-06-18	Promed Research Centre	Ophthalmic composition comprising phenylephrine
US8030297B2 (en) *	2008-05-14	2011-10-04	Otonomy, Inc.	Controlled release corticosteroid compositions and methods for the treatment of OTIC disorders
US10517839B2 (en) *	2008-06-09	2019-12-31	Cornell University	Mast cell inhibition in diseases of the retina and vitreous
TW201023912A (en) *	2008-12-05	2010-07-01	Alcon Res Ltd	Pharmaceutical suspension
RU2402315C2 (ru) *	2009-01-21	2010-10-27	Федеральное государственное учреждение "МОСКОВСКИЙ НАУЧНО-ИССЛЕДОВАТЕЛЬСКИЙ ИНСТИТУТ ГЛАЗНЫХ БОЛЕЗНЕЙ ИМЕНИ ГЕЛЬМГОЛЬЦА ФЕДЕРАЛЬНОГО АГЕНТСТВА ПО ВЫСОКОТЕХНОЛОГИЧНОЙ МЕДИЦИНСКОЙ ПОМОЩИ"	Глазная лекарственная композиция репаративного действия
US20100227905A1 (en) *	2009-03-03	2010-09-09	Alcon Research, Ltd.	Pharmaceutical Composition for Delivery of Receptor Tyrosine Kinase Inhibiting (RTKi) Compounds to the Eye
US8912236B2 (en) *	2009-03-03	2014-12-16	Alcon Research, Ltd.	Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
AU2010221438C1 (en) *	2009-03-03	2015-01-29	Alcon Research, Ltd.	Pharmaceutical composition for delivery of receptor tyrosine kinase inhibiting (RTKi) compounds to the eye
WO2010135731A1 (en) *	2009-05-22	2010-11-25	Kaufman Herbert E	Preparations and methods for ameliorating or reducing presbyopia
US8299079B2 (en)	2009-05-22	2012-10-30	Kaufman Herbert E	Preparations and methods for ameliorating or reducing presbyopia
US20130149394A1 (en)	2010-08-27	2013-06-13	Wakamoto Pharmaceutical Co., Ltd.	Aqueous ophthalmic composition
TWI544922B (zh)	2011-05-19	2016-08-11	愛爾康研究有限公司	高濃度歐羅派特錠（ｏｌｏｐａｔａｄｉｎｅ）眼用組成物
WO2013169458A1 (en) *	2012-05-11	2013-11-14	Bausch & Lomb Incorporated	Pharmaceutical compositions and methods for treating, controlling, ameliorating, or reversing conditions of dry eye
RU2485939C1 (ru) *	2012-06-19	2013-06-27	Станислав Анатольевич Кедик	Офтальмологический препарат в виде глазных капель, содержащий дисульфирам и таурин
US10507245B2 (en) *	2012-07-19	2019-12-17	Luis Felipe Vejarano Restrepo	Ophthalmic formulation and method for ameliorating presbyopia
RU2517033C1 (ru) *	2013-03-05	2014-05-27	федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения Российской Федерации	Композиция для комплексного лечения больных с первичной открытоугольной глаукомой и заболеваниями глазной поверхности
CN103239390B (zh) *	2013-05-15	2014-08-06	中国人民解放军第三军医大学第二附属医院	托吡卡胺眼用温度敏感原位凝胶及其制备方法
EP3082868A1 (de) *	2013-12-20	2016-10-26	The Procter & Gamble Company	Stabiles flüssiges medikament mit diphenhydramin
JP6714247B2 (ja) *	2017-10-06	2020-06-24	有限会社ジーエヌコーポレーション	尿道狭窄治療剤および尿道狭窄治療方法
TWI820142B (zh) *	2018-05-29	2023-11-01	日商大塚製藥工場股份有限公司	外用組成物
KR102888598B1 (ko) *	2018-11-26	2025-11-20	아이비바 바이오파마, 인크.	약물 전달을 위한 약학적 생분해성 겔

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3311577A (en) *	1965-03-29	1967-03-28	Burton Parsons Chemicals Inc	Underwater contact lens solution
US4100271A (en) *	1976-02-26	1978-07-11	Cooper Laboratories, Inc.	Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
US4188373A (en) *	1976-02-26	1980-02-12	Cooper Laboratories, Inc.	Clear, water-miscible, liquid pharmaceutical vehicles and compositions which gel at body temperature for drug delivery to mucous membranes
DE2714065A1 (de) *	1977-03-30	1978-10-12	Boehringer Mannheim Gmbh	Instillationszubereitung
US4474752A (en) *	1983-05-16	1984-10-02	Merck & Co., Inc.	Drug delivery system utilizing thermosetting gels
US4474753A (en) *	1983-05-16	1984-10-02	Merck & Co., Inc.	Topical drug delivery system utilizing thermosetting gels
US4474751A (en) *	1983-05-16	1984-10-02	Merck & Co., Inc.	Ophthalmic drug delivery system utilizing thermosetting gels
US4478822A (en) *	1983-05-16	1984-10-23	Merck & Co., Inc.	Drug delivery system utilizing thermosetting gels
FR2588189B1 (fr) *	1985-10-03	1988-12-02	Merck Sharp & Dohme	Composition pharmaceutique de type a transition de phase liquide-gel
GB2203039B (en) *	1987-03-02	1990-10-24	American Cyanamid Co	Stable ophthalmic preparations containing acetazolamide
US5252318A (en) *	1990-06-15	1993-10-12	Allergan, Inc.	Reversible gelation compositions and methods of use
US5077033A (en) *	1990-08-07	1991-12-31	Mediventures Inc.	Ophthalmic drug delivery with thermo-irreversible gels of polxoxyalkylene polymer and ionic polysaccharide
MX9200339A (es) *	1991-01-28	1992-08-01	Hoechst Ag	Preparado para la liberacion controlada de sustancias activas, que son apropiadas como terapeuticos o para mejorar el crecimiento y el aprovechamiento de los piensos en rumiantes
AU679937B2 (en) *	1992-11-18	1997-07-17	Johnson & Johnson Consumer Products, Inc.	Extrudable compositions for topical or transdermal drug delivery

1993
- 1993-11-10 RU RU95122560A patent/RU2108112C1/ru not_active IP Right Cessation
- 1993-11-10 AT AT93924801T patent/ATE189772T1/de not_active IP Right Cessation
- 1993-11-10 AU AU54333/94A patent/AU668447B2/en not_active Expired
- 1993-11-10 HU HU9502086A patent/HU220864B1/hu not_active IP Right Cessation
- 1993-11-10 CA CA002153234A patent/CA2153234C/en not_active Expired - Fee Related
- 1993-11-10 ES ES93924801T patent/ES2141775T3/es not_active Expired - Lifetime
- 1993-11-10 WO PCT/JP1993/001636 patent/WO1994023750A1/ja not_active Ceased
- 1993-11-10 US US08/397,064 patent/US5624962A/en not_active Expired - Lifetime
- 1993-11-10 DE DE69327878T patent/DE69327878T2/de not_active Expired - Lifetime
- 1993-11-10 EP EP93924801A patent/EP0694310B1/de not_active Expired - Lifetime
- 1993-11-10 DK DK93924801T patent/DK0694310T3/da active
- 1993-11-10 KR KR1019950703156A patent/KR0162025B1/ko not_active Expired - Lifetime
- 1993-11-15 CN CN93121431A patent/CN1048393C/zh not_active Expired - Lifetime
- 1993-11-16 IL IL107626A patent/IL107626A/xx not_active IP Right Cessation
1995
- 1995-07-26 FI FI953575A patent/FI112778B/fi not_active IP Right Cessation
- 1995-08-14 NO NO19953189A patent/NO311635B1/no not_active IP Right Cessation

Also Published As

Publication number	Publication date
CN1048393C (zh)	2000-01-19
FI953575L (fi)	1995-07-26
CA2153234A1 (en)	1994-10-27
RU2108112C1 (ru)	1998-04-10
KR960700075A (ko)	1996-01-19
HU9502086D0 (en)	1995-09-28
WO1994023750A1 (fr)	1994-10-27
IL107626A0 (en)	1994-02-27
KR0162025B1 (ko)	1998-12-01
DE69327878D1 (de)	2000-03-23
DE69327878T2 (de)	2000-06-15
FI112778B (fi)	2004-01-15
HK1017805A1 (en)	1999-11-26
NO311635B1 (no)	2001-12-27
US5624962A (en)	1997-04-29
AU5433394A (en)	1994-11-08
EP0694310B1 (de)	2000-02-16
CA2153234C (en)	1999-02-16
EP0694310A1 (de)	1996-01-31
HU220864B1 (en)	2002-06-29
ES2141775T3 (es)	2000-04-01
DK0694310T3 (da)	2000-06-05
FI953575A0 (fi)	1995-07-26
HUT71676A (en)	1996-01-29
EP0694310A4 (de)	1996-04-24
CN1097593A (zh)	1995-01-25
NO953189L (no)	1995-08-14
AU668447B2 (en)	1996-05-02
NO953189D0 (no)	1995-08-14
IL107626A (en)	1997-09-30

Legal Events

Date	Code	Title	Description
2011-08-15	REN	Ceased due to non-payment of the annual fee

Publication	Publication Date	Title
ATE189772T1 (de)	2000-03-15	Unter wärmeeinwirkung reversibel gelierende medizinische zusammensetzung auf wasserbasis
ATE146073T1 (de)	1996-12-15	Verstärker zur ultraschalltherapie von erkrankungen sowie diesen enthaltende flüssige arzneimittelzusammensetzungen
SE8203906L (sv)	1982-12-30	Nytt bandage for administration av lekemedel
BR9306841A (pt)	1998-12-08	Composição farmacêutica processo para proporcionar um tratamento anti-histamínico o qual não induz qualquer arritmia cardíaca significativa em um paciente ser humano e uso de uma composição para a mnaufactura de um medicamento para uso em um tratamento anti-histamínico
DE69327432D1 (de)	2000-02-03	Heilmittel für wunden und hämorrhoiden
CY1109869T1 (el)	2014-09-10	Παραγωγη πεπτιδιων και φαρμακευτικα αποδεκτων αλατων τους, τροποι συνθεσης, χρησης και φαρμακευτικης συνθεσης
SE8800266L (sv)	1989-07-29	Kopplingsanordning i hudgenomgaang
DE3382641D1 (de)	1992-12-17	Arzneimittel fuer die therapeutische behandlung von alopezie.
UA28048C2 (uk)	2000-10-16	Катетер для ін'єкці] рідини або лікарського препарату в порожнисті органи і порожнини тіла, зокрема в коронарні судини і артерії
DE68910159D1 (de)	1993-12-02	Dosierform für Verabreichung in der Humanmedizin.
IT1193254B (it)	1988-06-15	Dispositivo per interventi chirurgici in cavita' del corpo umano
CY1110078T1 (el)	2015-01-14	Παρασκευασματα με ιωδιουχο ποβιδονη για την αγωγη τραυματων
BR0013222A (pt)	2002-07-09	Medicamento para aplicação tópica, uso de um xanteno halogenado, composição farmacêutica para administração tópica, e, método de tratamento
DE68926746D1 (de)	1996-08-01	Auf phosphozucker basierende antientzündliche und/oder immunitätsunterdrückende arzneimittel
DK0559145T3 (da)	2000-04-10	Lægemiddel til truende abort
NO810480L (no)	1981-08-14	Anologifremgangsmaate for fremstilling av terapeutisk aktive 1,3,4-oksadiazolylfenol-derivater
ATE173405T1 (de)	1998-12-15	Arzneimittel auf basis von hyaluronsäure
SE8501312D0 (sv)	1985-03-18	Etoposide oral dosage form
DE3877499D1 (de)	1993-02-25	2,6-diamino-3-phenyl-azo-pyridin enthaltendes tier- und humanarzneimittel mit antiviraler und antitumoraler aktivitaet.
IT1214658B (it)	1990-01-18	Esteri polisaccaridici e loro sali
HU209063B (en)	1994-03-28	Composition disinfecting and indicating body paris
KR900701307A (ko)	1990-12-01	항 비루스성 또는 항 박테리아성 화합물과 그 사용방법
FR2635006B1 (fr)	1990-10-19	Medicament destine a regulariser les secretions hormonales et a traiter la sterilite
IT1236834B (it)	1993-04-21	Complessi del 4-idrossi-2-metil-n--2-piridinil-2-h,2-benzotiazina-3- carbossiammide-1,1-diossido con cilodestrine, aventi azione anti- infiammatoria, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT7945204A0 (it)	1979-03-05	Composizione farmaceutica per la terapia delle sterilita' maschile